Trial Profile
Low-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 30 Jul 2011 New trial record